Closure of Trading Window
Awaiting price reaction for this filing.
Sangam Health Care Products Ltd has informed BSE that its trading window will remain closed from 1st January 2026 onwards, in line with SEBI's Prohibition of Insider Trading Regulations. The window will reopen only after 48 hours from the declaration of unaudited financial results for the quarter ending 31st December 2025. All designated persons and their immediate relatives have been barred from trading in the company's shares during this closed period. The company has stated that the date of the board meeting to consider the Q3 FY26 results will be communicated separately in due course.
This is a routine compliance announcement and does not directly affect the stock price. However, it signals that the company's Q3 FY26 (October-December 2025) results are expected to be announced in the near term, which investors should watch for.